YOLFTbeta
Spectral AI Inc.

Spectral AI Inc.

MDAI · NASDAQ · Healthcare / Medical Devices

1.30USD-0.05 (-3.70%)

Price History

Full chart

Market Stats

Previous Close1.35
Open1.36
Day Range1.26 – 1.39
52-Week Range1.18 – 2.97
Volume136.96K
Market Cap51.82M
P/E (TTM)0.00
Forward P/E52.36
EPS-0.32
Dividend Yield0.00%
Beta1.18
50-Day Avg1.62
200-Day Avg1.70

About

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images. Spectral AI, Inc. is headquartered in Dallas, Texas.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Vincent Stanley Capone Esq.
  • Employees65
  • Headquarters2515 McKinney Avenue, Dallas, TX, United States, 75201, USA
  • Websitehttps://www.spectral-ai.com

Leadership

  • Dr. John Michael DiMaio M.D.Founder & Chairman · b. 1956
  • Mr. Vincent Stanley Capone Esq.CEO & Corporate Secretary · b. 1967
  • Mr. Stanley MicekChief Operating Officer · b. 1962
  • Ms. Allison KumarHead of Regulatory Affairs & Clinical Trials · b. 1978
  • Mr. Louis PercocoGeneral Manager · b. 1960
  • Mr. Wensheng FanCo-Founder, Chief Innovation Strategist & Senior Advisor to the CEO · b. 1970
  • Mr. David McGuireChief Financial Officer · b. 1979
  • Ms. Darcy BajkoChief Commercial Officer · b. 1979

Financials

Income Statement

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-15.24M25.37M18.06M29.58M19.65M
Growth (%)--+66.47%-28.82%+63.83%-33.57%
Cost of Revenue-8.19M14.53M10.18M16.31M10.72M
Gross Profit-7.05M10.84M7.88M13.27M8.93M
Gross Margin-46.28%42.72%43.64%44.87%45.42%
Operating Expense-11.23M13.48M20.86M19.86M17.53M
Operating Income--4.18M-2.65M-12.98M-6.58M-8.60M
Operating Margin--27.42%-10.43%-71.91%-22.25%-43.78%
EBITDA--4.08M-2.24M-20.12M-11.49M-5.42M
EBITDA Margin--26.81%-8.82%-111.44%-38.85%-27.58%
Net Income--3.99M-2.91M-20.85M-15.31M-7.57M
Net Income Margin--26.17%-11.48%-115.50%-51.77%-38.53%
R&D----29.58M19.65M
R&D as % of Total Revenue----100.00%100.00%
Interest Expense---02.96M1.51M
Interest Expense % of Total Revenue---0.00%10.02%7.66%

Balance Sheet

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets164.90K18.54M18.72M10.69M12.10M21.41M
Total Liabilities140.57K4.79M6.72M12.40M19.35M27.13M
Total Equity24.32K13.75M12.00M-1.71M-7.25M-5.73M
Cash-16.12M14.17M4.79M5.16M15.39M
Total Debt40.00K583.00K1.20M1.29M4.69M10.09M
Net Debt40.00K-15.54M-12.97M-3.50M-467.00K-5.30M

Cash Flow

Currency: USD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.82M-2.92M-1.16M-13.24M-9.20M-9.92M
Investing Cash Flow-7.00K-7.00K----
Financing Cash Flow534.77K13.92M-785.00K3.84M9.57M20.12M
Capital Expenditure7.00K7.00K0000
Free Cash Flow--2.92M-1.16M-13.24M-9.20M-9.92M
FCF to OCF-100.24%100.00%100.00%100.00%100.00%

Earnings

Report DateJun 14, 2021Aug 16, 2021Nov 22, 2021Mar 31, 2022May 13, 2022Aug 12, 2022Nov 10, 2022Mar 31, 2023Jun 30, 2023Nov 29, 2023Mar 29, 2024May 7, 2024Aug 12, 2024Nov 6, 2024Mar 27, 2025May 15, 2025Aug 12, 2025Nov 11, 2025Mar 25, 2026May 13, 2026Aug 11, 2026Nov 10, 2026
EPS Estimate0.000.000.000.000.000.000.000.00---0.22-0.26-0.16-0.19-0.14-0.41-0.08-0.08-0.14-0.07-0.14-0.14
EPS Actual0.10-0.090.07-0.150.220.050.040.04-0.15-0.77-0.22-0.15-0.17-0.04-0.070.11-0.31-0.130.02-0.11-0.13-
Surprise----------0.00%42.31%-6.25%78.95%50.00%126.83%-287.50%-62.50%114.29%-53.43%7.14%-
Timing----------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap51.82M
Enterprise Value55.70M
Trailing P/E0.00
Forward P/E52.36
Price / Sales3.37
Price / Book26.08
EPS-0.32
Book Value-0.375
Revenue (TTM)15.39M
Gross Profit (TTM)6.61M
EBITDA-11.76M
Profit Margin-65.54%
Operating Margin-122.70%
Return on Equity-2308.32%
Return on Assets-41.89%
Shares Outstanding32.18M
Shares Float27.90M
Beta1.18
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 3 analystsTarget 5.11
  • Strong Buy
    2
  • Buy
    1

Ownership Breakdown

Institutions
19.60%
Insiders
13.13%
Retail / Other
67.27%

Top Institutional Holders

  • Highlander Partners, L.P.
    900.00K2.80%
  • Vanguard Capital Management, LLC
    726.29K2.26%
  • Geode Capital Management, LLC
    301.21K0.94%
  • Jane Street Group LLC
    221.00K0.69%
  • Bridgeway Capital Management, LLC
    199.00K0.62%
  • Vanguard Fiduciary Trust Co
    141.80K0.44%
  • BlackRock Inc
    122.25K0.38%
  • University Of Texas Investment Mgmt Co
    121.71K0.38%
  • UBS Group AG
    113.02K0.35%
  • Rathbone Brothers PLC
    87.05K0.27%
  • State Street Corp
    75.60K0.23%
  • Forum Financial Management, LP
    60.50K0.19%
  • Northern Trust Corp
    32.10K0.10%
  • XTX Topco Ltd
    27.09K0.08%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    733.17K2.28%
  • Bridgeway Ultra-Small Company
    287.00K0.89%
  • Fidelity Extended Market Index
    115.64K0.36%
  • iShares Micro-Cap ETF
    91.36K0.28%
  • Fidelity Series Total Market Index
    30.35K0.09%
  • Fidelity Total Market Index
    28.72K0.09%